biological source
goat
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
lyophilized powder
species reactivity
human
technique(s)
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 5-15 μg/mL, indirect ELISA: suitable, neutralization: suitable, western blot: 0.1 μg/mL
UniProt accession no.
application(s)
research pathology
storage temp.
−20°C
Gene Information
human ... TGFB3(7043)
General description
Transforming growth factor-β3 (TGF-β3) belongs to the TGF-β superfamily of secreted proteins. TGF-β3 has been implicated in the physiology of adult lung, brain and heart. The TGF-β family is involved in a variety of signaling pathways that involve serine/threonine protein kinases. TGF-β3 acts through binding to TGF-βR2 transmembrane receptor in mammals. The important pathways regulated by TGF-β3 are the Alk-5/SMAD, RhoA/Rho-kinase and MAPK pathways. TGF-β3 is involved in morphogenesis, development of palate, angiogenesis, induction of epithelial-mesenchymal transition Deregulation of TGF-β signaling has been implicated in many developmental syndromes and cancer progression
Anti-Transforming Growth Factor-b3 (TGF-β3) recognizes human and chicken TGF-β3. The antibody shows less than 25 % cross-reactivity with amphibian TGF-b5 and less than 10 % cross-reactivity with TGF-β1, TGF-β1.2, and TGF-β2. This antibody also shows less than 5 % cross-reactivity with recombinant human LAP (latency associated peptide, TGF-β1).
Anti-Transforming Growth Factor-b3 (TGF-β3) recognizes human and chicken TGF-β3. The antibody shows less than 25 % cross-reactivity with amphibian TGF-b5 and less than 10 % cross-reactivity with TGF-β1, TGF-β1.2, and TGF-β2. This antibody also shows less than 5 % cross-reactivity with recombinant human LAP (latency associated peptide, TGF-β1).
Immunogen
Recombinant chicken transforming growth factor-β3 (TGF-β3) expressed in Sf 21 cells.
Application
Anti- Transforming growth factor-β3 (TGF-β3) antibody may be used for immunoblotting at a working concentration of 0.1 μg/ml. For immunohistochemistry a working concentration of 5-15 μg/ml may be used. The antibody is suitable for neutralization reactions (ND50 is 0.01-0.05 μg/ml).
Physical form
Lyophilized from a 0.2 μm filtered solution of PBS with 5% trehalose.
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Marek Dudas et al.
Developmental biology, 266(1), 96-108 (2004-01-20)
Cleft palate is among the most common birth defects in humans, caused by a failure in the complex multistep developmental process of palatogenesis. It has been recently shown that transforming growth factor beta3 (Tgf-beta3) is an absolute requirement for successful
Wing-Yee Lui et al.
Endocrinology, 144(4), 1139-1142 (2003-03-18)
Recent studies using Sertoli cells cultured in vitro to permit tight junction (TJ) assembly have shown that TJ dynamics are regulated, at least in part, by TGF-beta3 via the p38 mitogen activated protein (MAP) kinase pathway. This in turn regulates
Vesa Kaartinen et al.
International journal of molecular medicine, 9(6), 563-570 (2002-05-16)
TGFbeta-induced epithelio-mesenchymal transdifferentiation (EMT) has been shown to play a pivotal role in developmental processes such as palatogenesis and heart organogenesis. Interestingly, EMT has also been shown to contribute to the promotion of invasiveness during the later stages of tumorigenesis.
R Derynck et al.
The EMBO journal, 7(12), 3737-3743 (1988-12-01)
A new type of TGF-beta, TGF-beta 3, has been identified by cDNA characterization. The amino acid sequence of mature TGF-beta 3 and its precursor has been derived from porcine and human cDNA sequences. The human TGF-beta 3 gene is spread
Carl-Henrik Heldin et al.
FEBS letters, 586(14), 1959-1970 (2012-06-20)
Transforming growth factor-β (TGFβ) suppresses tumor formation since it inhibits cell growth and promotes apoptosis. However, in advanced cancers TGFβ elicits tumor promoting effects through its ability to induce epithelial-mesenchymal transition (EMT) which enhances invasiveness and metastasis; in addition, TGFβ
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持